Cookie Use Notification

This site uses cookies to provide you with a more responsive and personalised service.

By using this site you agree to our use of cookies as set out in our cookie notice. Please read our cookie notice for more information on the cookies we use and how to delete or block the use of cookies.

PCI Pharma Services expands in Tredegar

Click to Enlarge
US owned PCI Pharma Services has acquired 26,500 sq ft at Unit 6 Tafarnaubach Industrial Estate in Tredegar in a continued expansion of its operations as a fully integrated service provider for the global healthcare industry.

The company, which acquired Tredegar based Penn Pharma in July 2014, has taken a lease of Unit 6 Tafarnaubach Industrial Estate to expand their operations on the estate, supplementing their purpose-built contained manufacturing facility. Cushman & Wakefield acted on behalf of the landlord, Ashtenne Industrial Fund LLP.

Chris Yates, Senior Surveyor in Cushman & Wakefield’s industrial agency team in Cardiff commented: “We are delighted to have facilitated a major local employer in PCI Pharma Services expand their operations at Tafarnaubach Industrial Estate. Our client, Ashtenne Industrial Fund LLP, demonstrated their commitment and proactive asset management by undertaking a comprehensive refurbishment of the property, which ultimately paid dividends. The property further benefits from good quality two storey office accommodation, is situated on a secure site of 2.8 acres and has excellent road communications, adjacent to the A465 Heads of the Valleys Road – all of which were recognised by PCI”.

Norman Barras, Managing Director of PCI Pharma Services based in Tredegar, added: “The Tredegar site has benefited from significant investment over recent years and I am delighted that we are continuing to grow as a site. This additional footprint will ensure we are able to meet our growth demands moving forward.”